La cadena de opciones muestra datos clave de las opciones de acciones de LexinFintech Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para LexinFintech Holdings..

LexinFintech Holdings (NASDAQ:LX) Bolsa, Cadena de Opciones

LexinFintech Holdings

LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.

Movers_Stocks

AAOI

AFYA

AKBA

BTBT

CVNA

DOCU

FUTU

GDOT

QBTS

RBRK

RDUS

RGNX

RGTI

SMTC

SOUN

ULTA

Semtech sorprendió al mercado con ingresos y ganancias superiores a lo esperado. Inversores reaccionan ante este sólido desempeño trimestral.

Semtech, Rubrik, DocuSign, PagerDuty y otras acciones estadounidenses que suben el viernes

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

APCX

Descubre por qué LexinFintech (LX) y AppTech Payments (APCX) están lanzando señales de advertencia a los inversores.

Acciones sobrecompradas en el sector financiero: LexinFintech y AppTech Payments

LexinFintech Holdings Ltd. - American Depositary Shares

LexinFintech Holdings Ltd

Lux Amber Corp

Lixiang Education Holding Co., Ltd. - American Depositary Shares

Lixiang Education Holding Co Ltd

LITHIUM ENERGI EXPL INC by Lithium Energi Exploration Inc.

Lithium Energi Exploration Inc

Lexeo Therapeutics Inc

Luxfer Holdings PLC

LEXINGTON BIOSCIENCES by Lexington Biosciences Inc

Registered Plan Private Investments Inc

LXI REIT PLC by LXI REIT PLC

Eureka 93 Inc

LOXLEY PCL NVDR by Loxley Public Co., Ltd.

Loxley PCL

LXP Industrial Trust Common Stock (Maryland REIT)

LXP Industrial Trust

LENOX PASIFIK INVESTAMA by LENOX PASIFIK INVESTAMA TBK

PT Lenox Pasifik Investama Tbk

LXP Industrial Trust 6.5% Series C Cumulative Convertible Preferred Stock

LUXOR AS B by LUXOR AS

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals Inc

LSB Industries Inc

Lexagene Holdings Inc

LUXEY INTL HLDGS LTD by LUXEY INTL HLDGS LTD.

Forestar Group Now Expects To Deliver Between 14,500 And 15,000 Lots Compared To Prior Guidance Of Between 15,000 And 15,500 Lots

PulteGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>) reported quarterly earnings of $3.03 per share which beat the analyst consensus estimate of $3.00 by 0.83 percent. This is a 15.36 percent decrease over earnings of $3.58 per share from the same period last year. The company reported quarterly sales of $4.403 billion which missed the analyst consensus estimate of $4.411 billion by 0.17 percent. This is a 4.28 percent decrease over sales of $4.600 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

PulteGroup Q2 EPS $3.03 Beats $3.00 Estimate, Sales $4.403B Miss $4.411B Estimate

Guidance

Equifax Sees Q3 2025 Adj EPS $1.87-$1.97 vs $2.00 Est; Sees Sales $1.505B-$1.535B vs $1.52B Est

Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) affirms FY2025 sales outlook from $1.500 billion-$1.550 billion to $1.500 billion-$1.550 billion vs $1.553 billion estimate.

Forestar Group Affirms FY2025 Sales Guidance of $1.500B-$1.550B vs $1.553B Est

Compass Point analyst Ed Engel downgrades Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) from Neutral to Sell and lowers the price target from $205 to $130.

Downgrades

Price Target

Analyst Ratings

CRCL

Compass Point Downgrades Circle Internet Group to Sell, Lowers Price Target to $130

Forestar Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOR#NYSE">FOR</a>) reported quarterly earnings of $0.65 per share which missed the analyst consensus estimate of $0.77 by 15.91 percent. This is a 14.47 percent decrease over earnings of $0.76 per share from the same period last year. The company reported quarterly sales of $390.500 million which missed the analyst consensus estimate of $397.500 million by 1.76 percent. This is a 22.64 percent increase over sales of $318.400 million the same period last year.

Forestar Group Q3 EPS $0.65 Misses $0.77 Estimate, Sales $390.500M Miss $397.500M Estimate

Equifax Q2 2025 Adj. EPS $2.00 Beats $1.92 Estimate, Sales $1.54B Beat $1.51B Estimate

General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) reported quarterly earnings of $2.53 per share which beat the analyst consensus estimate of $2.40 by 5.2 percent. This is a 17.32 percent decrease over earnings of $3.06 per share from the same period last year. The company reported quarterly sales of $47.12 billion which beat the analyst consensus estimate of $45.57 billion by 3.41 percent. This is a 1.77 percent decrease over sales of $47.97 billion the same period last year.

General Motors Q2 Adj. EPS $2.53 Beats $2.40 Estimate, Sales $47.12B Beat $45.57B Estimate

HC Wainwright &amp; Co. analyst Robert Burns reiterates ArriVent BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVBP#NASDAQ">AVBP</a>) with a Buy and maintains $40 price target.

Reiteration

AVBP

HC Wainwright & Co. Reiterates Buy on ArriVent BioPharma, Maintains $40 Price Target

D.R. Horton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) narrows FY2025 sales outlook from $33.30 billion-$34.80 billion to $33.70 billion-$34.20 billion vs $33.82 billion estimate.

D.R. Horton Narrows FY2025 Sales Guidance from $33.30B-$34.80B to $33.70B-$34.20B vs $33.82B Est

More and more Americans are choosing to move their funds from traditional checking and savings accounts to investment income vehicles. 
What Happened: A study by the JPMorganChase Institute, which analyzed data from 4.7 million households, found that total cash reserves are increasing—driven by rising allocations to brokerage accounts, money market funds, and certificates of deposit, according to a report by&nbsp;<a href="https://abcnews.go.com/Business/wireStory/americans-shift-money-checking-savings-accounts-investment-income-123922344?ref=biztoc.com">ABC News</a>.
Although inflation-adjusted balances in checking and savings accounts have remained flat, total cash reserves have been rising since mid-2024 and are approaching historical growth trends when broader account types are included.
&#8220;Families&nbsp;across many income bands are&nbsp;now seeing a turnaround in&nbsp;their total cash,&#8221; said&nbsp;Chris Wheat, president of the institute. He noted that the trend could be temporary and that the institute currently lacks enough evidence to determine if it will persist.
The study also found that households earning less than $35,000 annually saw their total cash balances grow at a yearly rate of 5% to 6%.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/politics/25/07/46511833/tim-burchett-shrugs-off-trumps-stupid-remark-doubles-down-on-jeffrey-epstein-files-push-doesnt-give-up-its-secrets-very-easy" target="_blank" rel="noreferrer noopener">Tim Burchett Shrugs Off Trump&#8217;s &#8216;Stupid&#8217; Remark, Doubles Down On Jeffrey Epstein Files Push: &#8216;Doesn&#8217;t Give Up Its Secrets Very Easy&#8217; &#8211; Benzinga</a>
Why It Matters: The Federal Reserve, led by Jerome Powell, had left its <a href="https://www.benzinga.com/personal-finance/management/25/06/46011739/jerome-powell-led-fed-has-left-interest-rate-unchanged-what-does-it-mean-for-savings-mortgages-credit-cards-and-your-bank-account">benchmark rate</a> unchanged at 4.25%-4.50% for a sixth straight meeting in June 2025. This decision resulted in microscopic earnings for everyday depositors, with the average interest on basic checking remaining at 0.07% and standard savings paying just 0.38%.
However, money market funds hit a record $7.4 trillion in July 2025, as <a href="https://www.benzinga.com/markets/equities/25/07/46337134/bill-ackman-cheers-money-market-funds-hitting-record-7-4-trillion-as-jerome-powell-snubs-trumps-rate-cut-demands">highlighted </a>by billionaire Bill Ackman, founder and CEO of Pershing Square Capital Management L.P.. This trend, along with the growth in total cash reserves, suggests that Americans are increasingly looking for alternative investment vehicles to maximize their earnings amid economic uncertainty.
READ MORE: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/07/46534359/here-are-7-habits-rich-people-use-to-build-and-maintain-wealth-how-many-are-part-of-your-routine">Here Are 7 Habits Rich People Use To Build And Maintain Wealth — How Many Are Part Of Your Routine?</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Personal Finance

More Americans Ditch Checking And Savings Account For These Higher-Yield Alternatives Amid Economic Jitters

D.R. Horton Q3 EPS $3.36 Beats $2.92 Estimate, Sales $9.22B Beat $8.79B Estimate

JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) has revamped the leadership of its internal research group, responsible for quantum computing and other advanced technologies. The bank has appointed a former State Street Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) executive to lead the team.
What Happened: Marco Pistoia, the former head of JPMorgan&#8217;s applied research group, has left the bank, as per a CNBC report <a href="https://www.cnbc.com/2025/07/21/jpmorgan-quantum-computing-leadership-state-street-exec.html">on</a> Monday.
Pistoia, a former International Business Machines Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) inventor, was instrumental in the group&#8217;s research into emerging technologies such as quantum computing, blockchain, and computer vision, among others.
The bank has replaced Pistoia with Rob Otter, the global head of digital technology and quantum computing at State Street. Otter, who previously led JPMorgan&#8217;s Onyx blockchain business, has a wealth of experience in the technology sector, having held roles at Barclays PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCS#NYSE">BCS</a>), Credit Suisse, and Goldman Sachs Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>).
See Also: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46521555/shiba-inu-surges-37-in-1-month-how-high-can-the-shib-price-go" target="_blank" rel="noopener">Shiba Inu Surges 37% In 1 Month: How High Can The SHIB Price Go?</a>
Charles Lim, another key figure in the research group as the bank&#8217;s global head for quantum communications and cryptography, has also left JPMorgan.
Why It Matters: Quantum computing is a rapidly evolving field with potential applications in various industries, including finance, drug development, and materials science.
The technology is expected to revolutionize the way complex problems are solved, with industry leaders like Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and IBM racing to develop commercial quantum computers.
Earlier this year, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) also made a significant move in the <a href="https://www.benzinga.com/25/02/43830761/microsoft-unveils-majorana-1-quantum-chip-races-against-google-and-nvidia-in-quantum-computing">quantum computing space</a>, unveiling its Majorana 1 quantum chip. The company&#8217;s CEO, Satya Nadella, has highlighted the potential of quantum computing <a href="https://www.benzinga.com/markets/tech/25/06/46111393/ai-is-already-speeding-up-discoveries-in-chemistry-and-physics-but-satya-nadella-says-the-real-breakthrough-will-come-when-we-add-quantum-computing-to-the-mix">as the next game-changer</a> in scientific breakthroughs.
In June 2025, Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang <a href="https://www.benzinga.com/markets/tech/25/06/45885805/nvidias-jensen-huang-sparks-quantum-stock-frenzy">reversed his earlier skepticism</a> on quantum computing, now saying the technology is nearing a breakthrough and will soon tackle real-world problems beyond the reach of traditional computers.
Huang called quantum computing an &#8220;inflection point&#8221; and revealed that Nvidia is releasing a quantum algorithm stack for its advanced Grace Blackwell 200 chip. His optimism sparked a rally in quantum stocks, marking a sharp contrast to his January comments, when he predicted practical quantum applications were still decades away.
Price Action: JPMorgan Chase shares were up 0.17% at $291.47 in Tuesday's pre-market trading, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next:
<ul class="wp-block-list">
<li> <a href="https://benzinga.com/etfs/broad-u-s-equity-etfs/25/07/46535966/peter-thiel-effect-cathie-wood-pours-175-million-into-bitmine-immersion-stock-as-founders-fund-backing-ethereum-spike-fuels-buzz" target="_blank" rel="noopener">Peter Thiel Effect? Cathie Wood Pours $175 Million Into Bitmine Immersion Stock As Founders Fund Backing, Ethereum Spike Fuels Buzz &#8211; Grayscale Ethereum Mini Trust (ETH) Common units of fractional und</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Tech

GOOG

GOOGL

MSFT

NVDA

JPMorgan Chase Shakes Up Quantum Computing Division, Recruits State Street's Rob Otter As Marco Pistoia, Charles Lim Exit

HC Wainwright &amp; Co. analyst Emily Bodnar maintains SAB Biotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SABS#NASDAQ">SABS</a>) with a Buy and lowers the price target from $10 to $9.

SABS

HC Wainwright & Co. Maintains Buy on SAB Biotherapeutics, Lowers Price Target to $9

BYD Co. Ltd. (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDY#OTC">BYDDY</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BYDDF#OTC">BYDDF</a>) is going ahead full steam with its global expansion plans as the Chinese EV giant's luxury brand, Yangwang, will officially enter the European market next year.
What Happened: Yangwang's debut in Europe will follow the launch of BYD's other sub-brand Denza early next year, Stella Li, BYD's Vice President, told Autocar <a href="https://www.autocar.co.uk/car-news/new-cars/byd-primes-bentley-rivalling-yangwang-brand-european-launch">on</a> Monday.
Li said that Yangwang cars, including the U9 and U8 as well as the U7 sedan, are all slated to launch in Europe next year.
However, the report does not highlight whether BYD plans to offer its cars at prices lower than would-be competitors like Ferrari and Bentley. BYD's EVs are subject to 17% tariffs by the EU, the report suggests, which could impact the Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rival's pricing strategy.
Why It Matters: The news comes as BYD's sales in the Chinese <a href="https://www.benzinga.com/markets/asia/25/07/46514949/tesla-rival-byds-domestic-sales-slip-8-in-june-analysts-slash-annual-delivery-projections-amid-ev-price-war-scrutiny">market are down 8%</a>, with many analysts adjusting the expected deliveries by the company for 2025. BYD has said it's targeting over 5.5 million units delivered this year.
However, the company's <a href="https://www.benzinga.com/markets/tech/25/07/46187880/tesla-rival-byd-launches-11000-long-range-trim-of-its-best-selling-seagull-ev-as-price-war-heats-up">aggressive pricing strategy</a> has triggered concerns among the government officials in Beijing, who have vowed to <a href="https://www.benzinga.com/markets/tech/25/07/46460051/china-says-it-will-regulate-phenomenon-of-irrational-competition-amid-ev-price-war-report">regulate the "irrational" EV price war</a> in the country.
Elsewhere, rival Tesla recorded over <a href="https://www.benzinga.com/markets/tech/25/07/46538423/tesla-weekly-sales-in-china-fall-nearly-20-slipping-below-10k-units">9.9k new insured registrations</a> in the Chinese market during the week between July 14 to July 20, in what is a slowdown of sales for Elon Musk's EV giant.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="http://www.benzinga.com/markets/asia/25/07/46512860/tesla-rival-geelys-zeekr-neta-inflated-sales-data-in-china-through-insurance-scheme-amid-zero-mileage-used-cars-row-report">Tesla Rival Geely&#8217;s Zeekr, Neta Inflated Sales Data In China Through Insurance Scheme Amid &#8216;Zero-Mileage&#8217; Used Cars Row: Report</a></li>
</ul>
Photo courtesy: Tada Images / Shutterstock.com

BYDDF

BYDDY

TSLA

Tesla Rival BYD's Global Expansion Continues As Luxury Brand Yangwang Set For European Debut In 2026

Keybanc analyst Philip Gibbs upgrades Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) from Sector Weight to Overweight and announces $14 price target.

Upgrades

Keybanc Upgrades Cleveland-Cliffs to Overweight, Announces $14 Price Target

Oscar Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) raises FY2025 sales outlook from $11.200 billion-$11.300 billion to $12.000 billion-$12.200 billion vs $11.320 billion estimate.

OSCR

Oscar Health Raises FY2025 Sales Guidance from $11.200B-$11.300B to $12.000B-$12.200B vs $11.320B Est

Nano Labs Expands BNB Strategic Reserve To 120,000 Tokens ($90 M) And Announces Plan To Upgrade BNB Reserve Strategy

PEBO

Peoples Bancorp Declared A Quarterly Cash Dividend Of $0.41 Per Common Share On July 21, 2025, Payable On August 18, 2025, To Shareholders Of Record On August 4, 2025

Balance Sheet, Liquidity, &amp; Capital&nbsp;
• Loan receivables of $99.8 billion, including the movement of $0.2 billion to held for sale, decreased 2%; purchase volume decreased 2% and average active accounts decreased 4%.&nbsp;
• Deposits decreased $838 million to $82.3 billion and comprised 84% of funding.&nbsp;
• Total liquid assets were $21.8 billion, or 18.1% of total assets.&nbsp;
• The Company returned $614 million in capital to shareholders, including $500 million of share repurchases and $114 million of common stock dividends.&nbsp;
• As of June 30, 2025, the Company had a total remaining repurchase authorization of $2.0 billion for the period ending June 30, 2026.&nbsp;
• The estimated Common Equity Tier 1 ratio was 13.6% compared to 12.6%, and the estimated Tier 1 Capital ratio was 14.8% compared to 13.8% in the prior year

Synchrony Financial Q2 Loan Receivables Fall 2% To $99.8B; Purchase Volume Down 2%, Active Accounts Drop 4%

Press Releases

LexinFintech Holdings Ltd. Reports Second Quarter 2024 Unaudited Financial Results

LexinFintech Holdings Ltd. to Report Third Quarter 2024 Unaudited Financial Results on November 25, 2024

LexinFintech Holdings Ltd. Reports Third Quarter 2024 Unaudited Financial Results

LexinFintech Holdings Ltd. to Report Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 18, 2025

LexinFintech Holdings Ltd. Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results

LexinFintech Holdings Ltd. to Report First Quarter 2025 Unaudited Financial Results on May 21, 2025

LexinFintech Holdings Ltd. Reports First Quarter 2025 Unaudited Financial Results

Lexin Delivers Strong Q1 2025 Results with Profit at a Three-Year High, Highlighting the Growing Strength of Its Multi-Business Ecosystem

Driven by AI agents and large models powering new quality productive forces, LexinFintech wins The Asian Banker 's Best AI Technology for Financial Technology Company in China

Management

LexinFintech Holdings Ltd. Announces US$50 million Share Repurchase Program and Management Purchase

Ally Financial

American Express

Bread Financial Holdings, Inc. Common Stock

Bread Finl Hldgs

Credit Acceptance Corporation - Common Stock

Credit Acceptance

Capital One Financial Corporation Common Stock

Capital One Finl

Dave

Encore Capital Gr

Enova International

EZCORP, Inc. - Class A Non-Voting Common Stock

EZCORP

FirstCash Hldgs

FinVolution Group American Depositary Shares

FinVolution Group

Jiayin Group Inc. - American Depositary Shares

Jiayin Gr

Joint Stock Company Kaspi.kz - American Depository Shares

Kaspi.kz

LendingClub

Lufax Holding Ltd American Depositary Shares, each representing two (2) Ordinary Shares

Comments

LexinFintech Holdings

LexinFintech Holdings (LX) Opciones

LexinFintech Holdings (NASDAQ:LX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL